PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19

PHASE2TerminatedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

January 27, 2023

Study Completion Date

April 14, 2023

Conditions
COVID-19
Interventions
DRUG

PBI-0451 (Pomotrelvir)

2 × 350 mg tablets administered orally twice daily (BID) (1400 mg/day) with food for 5 days (10 total doses)

DRUG

Placebo

2 × placebo to match PBI-0451(Pomotrelvir) tablets administered orally BID with food for 5 days (10 total doses)

Trial Locations (54)

29169

Clinovacare Medical Clinical Research Center, West Columbia

Veritas Health Care Group, West Columbia

30328

Agile Clinical Research Trials, LLC, Atlanta

31904

Centricity Research - Roswell - HyperCore - PPDS, Columbus

32174

Ormond Beach Clinical Research, Ormond Beach

32803

Combined Research Orlando Phase I-IV LLC, Orlando

32958

Infectious Disease Consultants of the Treasure Coast, Sebastian

33027

EMINAT Research, Miramar

33125

Gonzalez M.D. & Aswad M.D. Health Care Services, Miami

33126

Universal Medical and Research Center, LLC, Miami

33155

Florida International Medical Research, Miami

33157

Beautiful Minds Clinical Research Center, Cutler Bay

33166

South Florida Research, Miami Springs

33175

P&S Research, LLC, Miami

33321

DBC Research, Tamarac

33406

CTMD Research, Inc. - Palm Springs - Hunt - PPDS, Palm Springs

33409

Palm Beach Research - ClinEdge - PPDS, West Palm Beach

45377

STAT Research, Vandalia

45424

WellNow Urgent Care Troy Urgent Care, Dayton

48312

Revival Research Corporation - Clinedge - PPDS, Sterling Heights

75057

Epic Clinical Research, Lewisville

75211

Mercy Family Clinic, Houston

77084

Diversified Medical Practices, P.A., Houston

78230

VIP Trials, San Antonio

78705

Central Texas Clinical Research, Austin

85210

Voyage Medical, Mesa

91303

Hope Clinical Research, LLC, Canoga Park

91436

Biopharma Informatic, LLC, Encino

92868

Ark Clinical Research - Long Beach - Clinedge - PPDS, Long Beach

93301-1692

Franco A Felizarta MD, Bakersfield

92835-3424

Ascada Research LLC, Fullerton

91356-6695

Valiance Clinical Research, Tarzana

92683-4454

Allianz Research Institute - Colorado, Westminster

33511-4850

TrueBlue Clinical Research- Brandon - HyperCore - PPDS, Brandon

33012-4174

Indago Research and Health Center, Hialeah

33016-1811

Quality Research of South Florida, Hialeah

33133-4231

CCM Clinical Research Group, Miami

33155-3262

D&H National Research Centers, Miami

33155-4630

Allied Biomedical Research Institute, Miami

33016-1641

The Angel Medical Research Corporation, Miami Lakes

33157-5503

IMIC Inc., Palmetto Bay

33143-5045

Westchester General Hospital, South Miami

33615-3816

Alliance Clinical Research-(Tampa), Tampa

60621-3116

Eagle Clinical Research, Chicago

39056-5606

Safe Haven Clinical Research, Clinton

59701-1652

Mercury Street Medical Group, Butte

89128-0373

Las Vegas Medical Research, Las Vegas

28037-7929

Research Carolina Elite, Denver

37067-5663

Clinical Trials Center of Middle Tennessee, Franklin

75230-6895

Zenos Clinical Research, Dallas

78539-4660

Proactive Clinical Research, LLC Edinburg, Edinburg

75126-4174

Care United Research, LLC, Forney

77036-8280

Xpress Trials, Houston

23435-3762

Suffolk Multispecialty Research, Suffolk

Sponsors
All Listed Sponsors
lead

Pardes Biosciences, Inc.

INDUSTRY